News|Articles|August 28, 2023
How to Pave an Expressway to Phase I – Strategies That Accelerate Your Early-Phase Programs
Author(s)Wuxi
Speed is a critical factor in early-stage development. Solid state studies within an integrated CMC platform can support formulation development, accelerate timelines to Phase I clinical studies and increase the likelihood of successful clinical trial results.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
Lilly Invests $3.5B in Pennsylvania Injectable Medicine Facility
2
PharmTech Weekly News Roundup – Week of January 26, 2026
3
Repertoire Immune Medicines and Lilly Collaborate on Treatments for Autoimmune Diseases
4
Vetter Announces Plan to Build Manufacturing Site in Germany with €1.5 Billion CDMO Investment
5